{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:56:36Z","timestamp":1785214596255,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T00:00:00Z","timestamp":1488931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.02.059","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T06:02:29Z","timestamp":1489471349000},"page":"1996-2006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"35","author":[{"given":"Louise E.","family":"Lansbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4143-5364","authenticated-orcid":false,"given":"Sherie","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Karamehic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Pasic-Juhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Sikira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mateus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Oshitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Nguyen-Van-Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.02.059_b0005","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/j.vaccine.2012.02.048","article-title":"Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses","volume":"30","author":"Yin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1750-2659.2011.00229.x","article-title":"Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis","volume":"5","author":"Yin","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2017.02.059_b0020","unstructured":"Beck C, Nguyen-Van-Tam J, Lansbury L, Smith S. Efficacy and effectiveness of 2009 pandemic influenza A(H1N1) vaccines: a systematic review and meta-analysis. PROSPERO 2014:CRD42014014384."},{"key":"10.1016\/j.vaccine.2017.02.059_b0025","unstructured":"European Centre for Disease Prevention and Control. Narcolepsy in association with pandemic influenza vaccination (A multi-country European epidemiological investigation). Stockholm: ECDC; September 2012."},{"key":"10.1016\/j.vaccine.2017.02.059_b0030","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.059_b0035","unstructured":"Medical Products Agency Sweden. Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations. Results of a case inventory study by the MPA in Sweden during 2009\u20132010. Available from: <http:\/\/www.lakemedelsverket.se\/upload\/nyheter\/2011\/Fallinventeringsrapport_pandermrix_110630.pdf> [accessed 19\/12\/2016]."},{"key":"10.1016\/j.vaccine.2017.02.059_b0040","unstructured":"Medical Products Agency Sweden. A registry based comparative cohort study in four Swedish counties of the risk for narcolepsy after vaccination with Pandemrix \u2013 A first and preliminary report, by the Medical Products Agency. Available from: <http:\/\/www.lakemedelsverket.se\/upload\/nyheter\/2011\/PandemrixRegReport110328.pdf> (accessed 19\/12\/2016)."},{"key":"10.1016\/j.vaccine.2017.02.059_b0045","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2017.02.059_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023085","article-title":"Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities","volume":"6","author":"Griffin","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.059_b0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/infdis\/jis306","article-title":"Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years","volume":"206","author":"Hadler","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0060","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/infdis\/jis441","article-title":"Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in Maine","volume":"206","author":"Uzicanin","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0065","unstructured":"Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from <www.cochrane-handbook.org>."},{"key":"10.1016\/j.vaccine.2017.02.059_b0070","unstructured":"Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (last accessed 19\/12\/16)."},{"key":"10.1016\/j.vaccine.2017.02.059_b0075","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.vaccine.2013.02.053","article-title":"The test-negative design for estimating influenza vaccine effectiveness","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0080","unstructured":"West S, King V, Carey TS, Lohr KN, McKoy N, Sutton SF, et al. Systems to rate the strength of scientific evidence. Evidence report\/technology assessment (Summary). 2002:1\u201311."},{"key":"10.1016\/j.vaccine.2017.02.059_b0085","unstructured":"Systematic Reviews: CRD's guidance for undertaking reviews in health care: Centre for Reviews and Dissemination. University of York; 2009."},{"key":"10.1016\/j.vaccine.2017.02.059_b0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/infdis\/jiq014","article-title":"Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England","volume":"203","author":"Andrews","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0095","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3201\/eid1707.101959","article-title":"Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010","volume":"17","author":"Fielding","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0100","first-page":"85","article-title":"Effectiveness of mono-valent adjuvanted vaccine (Pandemrix) for the prevention of hospitalisation for influenza A (H1N1)v infection in children","volume":"99","author":"Hamrin","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2017.02.059_b0105","doi-asserted-by":"crossref","unstructured":"Hellenbrand W, Jorgensen P, Schweiger B, Falkenhorst G, Nachtnebel M, Greut\u00e9laers B, et al. Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009\u20132010 using matched hospital and test-negative controls. BMC Infect Dis. 12:127.","DOI":"10.1186\/1471-2334-12-127"},{"key":"10.1016\/j.vaccine.2017.02.059_b0110","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1016\/j.vaccine.2011.08.068","article-title":"Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study","volume":"29","author":"Mahmud","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0115","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1016\/j.vaccine.2012.07.009","article-title":"Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza","volume":"30","author":"Ortqvist","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0120","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1016\/j.vaccine.2010.09.042","article-title":"Effectiveness of seasonal 2008\u20132009, 2009\u20132010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital-based, case-control study","volume":"28","author":"Puig-Barbera","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0125","doi-asserted-by":"crossref","first-page":"c7297","DOI":"10.1136\/bmj.c7297","article-title":"Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009","volume":"342","author":"Skowronski","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2017.02.059_b0130","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.vaccine.2010.12.050","article-title":"Effectiveness of the pandemic influenza A\/H1N1 2009 monovalent vaccine in Korea","volume":"29","author":"Song","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0135","doi-asserted-by":"crossref","unstructured":"Uphoff H, An der Heiden M, Schweiger B, Campe H, Beier D, Helmeke C, et al. Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A\/(H1N1) 2009 \u2013 a comparison of two methods; Germany, 2009\/10. PLoS One. 2011;6:e19932-e.","DOI":"10.1371\/journal.pone.0019932"},{"key":"10.1016\/j.vaccine.2017.02.059_b0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1750-2659.2010.00146.x","article-title":"Protective effect of single-dose adjuvanted pandemic influenza vaccine in children","volume":"4","author":"Van Buynder","year":"2010","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2017.02.059_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063156","article-title":"Effectiveness of MF59 Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands","volume":"8","author":"Wijnans","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.059_b0150","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1016\/j.vaccine.2012.06.090","article-title":"Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization","volume":"30","author":"Dominguez","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0155","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4161\/hv.6.9.12638","article-title":"Effectiveness of H1N1 vacine against reported Influenza A (H1N1)","volume":"6","author":"Fu","year":"2010","journal-title":"Human Vaccines"},{"key":"10.1016\/j.vaccine.2017.02.059_b0160","doi-asserted-by":"crossref","first-page":"e66125","DOI":"10.1371\/journal.pone.0066125","article-title":"Effectiveness of A(H1N1)pdm09 influenza vaccine in adults recommended for annual influenza vaccination","volume":"8","author":"Gefenaite","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.059_b0165","doi-asserted-by":"crossref","first-page":"e1084","DOI":"10.1542\/peds.2010-3492","article-title":"Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children","volume":"128","author":"Gilca","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.02.059_b0170","first-page":"438","article-title":"Effectiveness of the pandemic H1N1 influenza vaccines in preventing hospitalization for influenza and pneumonia: a population-based case-control study","volume":"22","author":"Mahmud","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2017.02.059_b0175","first-page":"11","article-title":"A\/H1N1 influenza-related hospitalisation; a matched case-control study","volume":"2011","author":"Steens","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0180","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/cid\/cit551","volume":"57","author":"Thompson","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0185","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/irv.12025","article-title":"Factors associated with the transmission of pandemic (H1N1) 2009 among hospital healthcare workers in Beijing, China","volume":"7","author":"Zhang","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2017.02.059_b0190","doi-asserted-by":"crossref","first-page":"d7901","DOI":"10.1136\/bmj.d7901","article-title":"Effectiveness of vaccine against pandemic influenza A\/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009\u201310","volume":"344","author":"Emborg","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2017.02.059_b0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2334-12-63","article-title":"Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway","volume":"12","author":"Guzman Herrador","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0200","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.vaccine.2013.02.066","article-title":"Evaluation and sensitivity analysis of the effectiveness of unadjuvanted A(H1N1)pdm09 vaccine in hospital workers using multi-center cohort study in Korea","volume":"31","author":"Lim","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0205","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1006736","article-title":"Safety and effectiveness of a 2009 H1N1 vaccine in Beijing","volume":"363","author":"Wu","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.02.059_b0210","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00420-011-0714-8","article-title":"High effectiveness of pandemic influenza A (H1N1) vaccination in healthcare workers from a Portuguese hospital","volume":"85","author":"Costa","year":"2012","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.vaccine.2017.02.059_b0215","first-page":"661","article-title":"Epidemiological effects of the A (H1N1) influenza vaccine immunization program on students","volume":"32","author":"He","year":"2011","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2017.02.059_b0220","doi-asserted-by":"crossref","first-page":"e26572","DOI":"10.1371\/journal.pone.0026572","article-title":"Effectiveness of pandemic H1N1-2009 vaccination in reducing laboratory confirmed influenza infections among military recruits in tropical Singapore","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.059_b0225","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1016\/j.vaccine.2013.07.005","article-title":"Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010","volume":"31","author":"Njuguna","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0230","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/cid\/cir182","article-title":"Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden","volume":"52","author":"Ortqvist","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0235","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.healun.2011.01.707","article-title":"Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort","volume":"30","author":"Schuurmans","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.vaccine.2017.02.059_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108538","article-title":"Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in Adults: A clinical cohort study during epidemic seasons 2009\u20132010 and 2010\u20132011 in Finland","volume":"9","author":"Syrjanen","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.059_b0245","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vaccine.2011.11.013","article-title":"Screening method working g. Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009\u20132010","volume":"30","author":"Seyler","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0250","doi-asserted-by":"crossref","unstructured":"Wichmann O, Stocker P, Poggensee G, Altmann D, Walter D, Hellenbrand W, et al. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009\u20132010. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2010;15.","DOI":"10.2807\/ese.15.18.19561-en"},{"key":"10.1016\/j.vaccine.2017.02.059_b0255","doi-asserted-by":"crossref","unstructured":"Broadbent AJ, Subbarao K. Influenza virus vaccines: lessons from the 2009 H1N1 pandemic. Curr Opin Virol. 1:254-62.","DOI":"10.1016\/j.coviro.2011.08.002"},{"key":"10.1016\/j.vaccine.2017.02.059_b0260","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2010.04.083","article-title":"Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009\u20132010 and comparison with previous estimates and global action plan targets","volume":"28","author":"Partridge","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0265","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.vaccine.2013.02.017","article-title":"Live attenuated seasonal and pandemic influenza vaccine in school-age children: a randomized controlled trial","volume":"31","author":"Klick","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.059_b0270","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4161\/hv.27490","article-title":"Effectiveness of an Indian-made attenuated influenza A(H1N1)pdm 2009 vaccine: a case control study","volume":"10","author":"Kulkarni","year":"2014","journal-title":"Human Vacc Immunother"},{"key":"10.1016\/j.vaccine.2017.02.059_b0275","doi-asserted-by":"crossref","first-page":"e13755","DOI":"10.1371\/journal.pone.0013755","article-title":"Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials","author":"Mallory","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.059_b0280","doi-asserted-by":"crossref","unstructured":"Ambrose CS, Bright H, Mallory R. Letter to the editor: potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2016;21.","DOI":"10.2807\/1560-7917.ES.2016.21.45.30394"},{"key":"10.1016\/j.vaccine.2017.02.059_b0285","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/irv.12074","article-title":"Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries","volume":"7","author":"Van Kerkhove","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2017.02.059_b0290","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1010331","article-title":"Oil-in-water emulsion adjuvant with influenza vaccine in young children","volume":"365","author":"Vesikari","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.02.059_b0295","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1093\/cid\/ciu1175","article-title":"Estimating the potential effects of a vaccine program against an emerging influenza pandemic\u2013United States","volume":"60","author":"Biggerstaff","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0300","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3201\/eid1903.120394","article-title":"Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009\u20132010","volume":"19","author":"Borse","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0305","unstructured":"World Health Organization. Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits; 2011."},{"key":"10.1016\/j.vaccine.2017.02.059_b0310","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S1473-3099(08)70232-9","article-title":"Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans","volume":"8","author":"Jennings","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0315","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(10)70296-6","article-title":"Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial","volume":"11","author":"Nicholson","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.059_b0320","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s11538-011-9704-y","article-title":"Modeling optimal age-specific vaccination strategies against pandemic influenza","volume":"74","author":"Lee","year":"2012","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.vaccine.2017.02.059_b0325","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3934\/mbe.2011.8.95","article-title":"Prioritization of delayed vaccination for pandemic influenza","volume":"8","author":"Shim","year":"2011","journal-title":"Math Biosci Eng"},{"key":"10.1016\/j.vaccine.2017.02.059_b0330","article-title":"Community-acquired pneumonia distinguished from influenza infection based on clinical signs and symptoms during a novel (swine) influenza A\/H1N1 pandemic","volume":"02","author":"Nakanishi","year":"2011","journal-title":"Primary Care Respiratory J"},{"key":"10.1016\/j.vaccine.2017.02.059_b0335","doi-asserted-by":"crossref","unstructured":"Pebody RG, Green HK, Andrews N, Boddington NL, Zhao H, Yonova I, et al. Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014\/15. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2015;20.","DOI":"10.2807\/1560-7917.ES.2015.20.39.30029"},{"key":"10.1016\/j.vaccine.2017.02.059_b0340","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/aje\/kwp072","article-title":"Optimal dosing and dynamic distribution of vaccines in an influenza pandemic","volume":"169","author":"Wood","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.02.059_b0345","doi-asserted-by":"crossref","first-page":"B6","DOI":"10.1016\/j.vaccine.2015.03.026","article-title":"The narcolepsy-pandemic influenza story: can the truth ever be unraveled?","volume":"33","author":"Sturkenboom","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T03:09:28Z","timestamp":1658804968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17302724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":69,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17302724"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}